Stay updated with breaking news from Nasdaq Ccxi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investing in mid-cap stocks is essential for investors who prefer a diversified portfolio. These stocks offer a middle ground with regard to the risks
Zurcher Kantonalbank Zurich Cantonalbank lessened its position in shares of ChemoCentryx, Inc. (NASDAQ:CCXI – Get Rating) by 16.9% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 7,919 shares of the biopharmaceutical company’s stock after selling 1,615 shares during the quarter. Zurcher Kantonalbank Zurich […]
Shares of ChemoCentryx, Inc. (NASDAQ:CCXI – Get Rating) have been given a consensus rating of “Buy” by the eight brokerages that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, five have given a buy rating and one has assigned a […]
ChemoCentryx, Inc. (NASDAQ:CCXI – Get Rating) has earned an average recommendation of “Buy” from the eight analysts that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, five have issued a buy recommendation and one has given a strong buy […]
-- David E. Wheadon, M.D., Elected to the Board as an Independent Director -- -- Henry A. McKinnell, Jr., to Retire from Board -- SAN CARLOS, Calif., May...